Shenzhen Pinxuan Culture and Art Co., Ltd – Trademark Portfolio

Entity Type: 99

Shenzhen Pinxuan Culture and Art Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FACENTRUM. The owner is based in Guangdong.

Room 302, No. 311 Jihua Road, Shuijing Community Jihua Street, Longgang District, Shenzhen,

Guangdong 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FACENTRUM
FACENTRUM
Registered 2025

Trademark Classifications

Shenzhen Pinxuan Culture and Art Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Pinxuan Culture and Art Co., Ltd have?

Shenzhen Pinxuan Culture and Art Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Pinxuan Culture and Art Co., Ltd file in?

Shenzhen Pinxuan Culture and Art Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Pinxuan Culture and Art Co., Ltd's most well-known trademarks?

Shenzhen Pinxuan Culture and Art Co., Ltd's registered trademark portfolio includes well-known marks such as FACENTRUM. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Pinxuan Culture and Art Co., Ltd's trademark registration success rate?

Shenzhen Pinxuan Culture and Art Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.